An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand

British Journal of Haematology

Volumn 94, Issue 2, 1996, Pages 379-382

  Sato, Ken ^a   Kimura, Fumihiko ^a   Nakamura, Yukitsugu ^a   Murakami, Hideaki ^a   Yoshida, Masayoshi ^a   Tanaka, Masato ^b   Nagata, Shigekazu ^b,c   Kanatani, Yasuhiro ^a   Wakimoto, Naoki ^a   Nagata, Naokazu ^a   Motoyoshi, Kazuo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

apoptosis; Fas; Fas ligand; liver damage; lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; TUMOR NECROSIS FACTOR; VINCRISTINE; AMINOTRANSFERASE; BILIRUBIN; CD45RO ANTIGEN; FAS LIGAND; HEMOGLOBIN; METHYLPREDNISOLONE; SOLUBLE FAS LIGAND; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; LIVER INJURY; LYMPHOMA; NOSE CANCER; PANCYTOPENIA; PRIORITY JOURNAL; ANTIGEN EXPRESSION; BLEEDING; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CAUSE OF DEATH; CHILL; DISSEMINATED INTRAVASCULAR CLOTTING; FEVER; HOSPITAL ADMISSION; HUMAN TISSUE; HYPOPLASIA; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LIVER FAILURE; LIVER FUNCTION; MALAISE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NASAL BIOPSY; NEUTROPHIL; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; NOSE OBSTRUCTION; NOSE TUMOR; RETICULOCYTE; SORE THROAT; THROMBOCYTE COUNT;

EID: 8944228467     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1799.x     Document Type: Article

References (12)

1. Anel. A., Buferne, M., Boyer, C., Schmitt-Verhulst, A.M. & Golstein, P. (1994) T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. European Journal of Immunology, 24, 2469-2476.
2. Arase, H., Arase, N. & Saito, T. (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells, Journal of Experimental Medicine, 181, 1235-1238.
3. Galle, P.R., Hofmann, W.J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P.H. & Runkel, L. (1995) Involvement of the CD95 (Apo-1/Fas) receptor and ligand in liver damage. Journal of Experimental Medicine, 182, 1223-1230.
4. Imamura, N., Kusunoki, Y., Kawa-ha, K., Yumura, K., Hara, J., Oda, K., Abe, K., Dohy, H., Inada, T., Kajihara, H. & Kuramoto, A. (1990) Aggressive natural killer cell leukocmia/lymphoma: report of four cases and review of the literature. British Journal of Haematology, 75, 49-59.
5. Nagata, S. & Golstein, P. (1995) The Fas death factor. Science, 267, 1449-1456.
6. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. & Nagata, S. (1993) Lethal effect of the anti-Fas antibody in mice. Nature, 364, 806-809.
7. Soler, J., Bordes, R., Ortuno, F., Montagud, M., Martorell, J., Pons, C., Nomdedeu, J., Lopez-Lopez, J.J., Prat, J. & Rutllant, M. (1994) Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma. British Journal of Haematology, 86, 659-662.
8. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. & Nagata, S. (1994) Expression of the Fas ligand in cells of T cell lineage. Journal of Immunology, 154, 3806-3813.
9. Suda, T., Takahashi, T., Golstein, P. & Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178.
10. Sun, T., Brody, J., Susin, M., Marino, J., Teichberg, S., Kodoru, P., Hall, W.W., Urmacher, C. & Hajdu, S.I. (1993) Aggressive natural killer cell lymphoma/leukemia: a recently recognized clinicopathologic entity. American Journal of Surgical Pathology, 17, 1289-1299.
11. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H. & Nagata, S. (1996) Fas ligand in human serum. Nature Medicine, 2, 317-322.
12. Tanaka, M., Suda, T., Takahashi, T. & Nagata, S. (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO Journal, 14, 1129-1135.